ViiV Healthcare
@ViiVHC
Followers
20K
Following
7K
Media
5K
Statuses
12K
100% dedicated to preventing, treating & curing HIV #WeWontStop Follow @ViiVUS for US updates. Social Media Code of Conduct: https://t.co/wr2meAR90D
United Kingdom
Joined February 2015
"Innovation gives me hope.” Watch Dr. Kimberly Smith talk about how advances in HIV care have made the hard things easier. Full video: https://t.co/1gAiXGMDR1
#WeWontStop #EndingHIV
0
1
4
#News for #Investors and #Media: Today at #CROI2026 we presented new insights on our investigational ultra-long-acting therapies. 👉 Find out more: https://t.co/P3NVIMgh2a
0
1
5
#News for #Investors and #Media: At #CROI2026 we’re presenting new data focused on informing treatment approaches for children and adolescents living with #HIV. Learn more 👉 https://t.co/P3NVIMgh2a
0
1
2
Test. Treat. Prevent. Shatter stigma. Ensure access. Keep working towards a cure. Watch Dr. Kimberly Smith outline the six steps to ending #HIV. Full video: https://t.co/1gAiXGMDR1
#WeWontStop #EndingHIV
0
1
6
#News for #Investors and #Media: Today at #CROI2026 we announced new analyses from the largest head-to-head randomised clinical trial studying two-regimen vs three-regimen HIV treatments.
0
2
7
#News for #Media and #Investors New data published in the New England Journal of Medicine compare efficacy of different forms of HIV treatment. https://t.co/G8liY4fW8P
0
0
0
"We have to address stigma. The reality is that it keeps people from getting tested” Watch Dr. Kimberly Smith discuss why we need more conversations about HIV. Full video: https://t.co/1gAiXGMDR1
#WeWontStop #EndingHIV
1
2
12
It’s National HIV Testing Week! HIV can affect anyone – and testing is the only way to know your status. This week, we’re encouraging everyone to get tested. It’s free, quick and confidential. Get your free test now: https://t.co/tXRIAbZDTi Funded by @ViiVHC
0
7
7
ViiV‑supported research highlighted in @TheLancetHIV, reflecting our commitment to innovation in HIV care for young people. https://t.co/XlIDElxJcZ
0
0
1
Our discussion with @newscientist "Unfinished Business: How do we end HIV?" is officially underway! Join experts Kim Smith, Babafemi Taiwo, @joseph_eron and @SLHWV, as they discuss science, stigma and the future of HIV care. Tune in now! https://t.co/i9ZAFT7Qc4
newscientist.com
Of the 40 million people living with HIV, nearly a quarter are not receiving life-saving treatment and new transmissions are not falling as fast as many experts hope. So how can the world meet the...
0
0
1
Join us and @newscientist for “Unfinished Business: How do we end HIV?”, a fast-paced roundtable discussion with Kimberly Smith, Babafemi Taiwo, @joseph_eron , and @SLHWV tackling the science, stigma and path to a potential HIV-free future. Register today!
newscientist.com
Of the 40 million people living with HIV, nearly a quarter are not receiving life-saving treatment and new transmissions are not falling as fast as many experts hope. So how can the world meet the...
0
0
0
#News for #Media: The movement continues with the launch of Risk to Reasons UK – two new guides created for women and healthcare professionals that encourage open and positive conversations about #HIV prevention. https://t.co/wfO5zPdpoK
#RiskToReasons #HIVPrevention
0
2
8
#News for #Investors and #Media: The National Institute for Health and Care Excellence (NICE) has recommended our HIV prevention regimen for use in England & Wales. For investors and media https://t.co/044AnhqU6K.
viivhealthcare.com
ViiV Healthcare is an independent HIV company, committed to delivering innovative new options for the care and treatment of people living with HIV/AIDS.
0
1
1
#News for #Investors and #Media: Data presented at #EACS2025 compare the tolerability and acceptability of innovative HIV medicines. Find out more 👉 https://t.co/044AnhqU6K
0
0
5
We're at a pivotal moment in the quest to end #HIV. Learn more about the transformational science fuelling our research in this @newscientist article with Jean van Wyk, Babafemi Taiwo, Sherene Min, and Annemiek de Ruiter: https://t.co/iVtV1f3ysj
1
0
8
#News for #Investors #Media We’ll be at #EACS2025 & #IDWeek2025, showcasing our innovation & real-world evidence from our #HIV treatment and prevention portfolio. Learn more: https://t.co/Y6CRbVUpBV
0
0
3
For some people living with #HIV, self-stigma is one of many challenges in managing their health. But HIV care is evolving. Prof. Antonella Castagna shares how personal choice and tailored options are reshaping HIV care. 👉Read the ViiV sponsored article: https://t.co/pgl6LmIvc7
2
1
12
INSTIs are recommended in many first-line #HIV regimens for their potency, long-term tolerability, and high barrier to resistance. Hear more: https://t.co/n44TG7QZHD
#WeWontStop
0
1
7
We’re exploring how broadly neutralising antibodies (bNAbs) can target and eliminate hidden #HIV reservoirs. Our Induce and Reduce strategy focuses on using bNAbs to drive the reservoir out of hiding, so it can be eliminated. Explore the research: https://t.co/MFW7rs0206
0
2
11
Innovation is giving people control of their #HIV care 🙌 We’ve partnered with @CNNCreate to tell the story about the real impact scientific innovation has on people’s lives. Learn more 👉 https://t.co/HsVvO4wztt Content by ViiV Healthcare
sponsorcontent.cnn.com
How transformative science is shaping HIV care
0
3
6